Comments 0

Presentation transcript

‹Genetic cassette is created with natural and synthetic DNA. Thiscombination could possibly be customized and used in genetherapy.

FDA approves:

‹“the first therapeutic antibody to treat cancer in the U.S.”

“the first bloodless HIV-antibody test that use cells from patients’gums.”

“a recombinant follicle stimulating hormone to treat infertility.”

At the Institute for Genomic Research, scientists sequence thegenome for the organism related to stomach ulcers and thepathogen of Lyme disease.

http://biotechnology.amgen.com/timeline-medical-biotechnology

Back toTImeline

1998

For the first time, human skin was created in a lab.

‹Embryonic stem cells are used to create disorders and mimic certaindiseases and to regenerate tissue.

‹Vaccine for Lyme disease is created.

“A monoclonal antibody therapy used against breast cancer hasfavorable results, heralding a new era of treatment based onmolecular targeting of tumor cells.”

http://biotechnology.amgen.com/timeline-medical-biotechnology

Back toTImeline

1999

The entire genetic code of the human chromosome is decoded.

Back toTImeline

http://biotechnology.amgen.com/timeline-medical-biotechnology

2000

A rough draft of the human genome is completed by scientist at theHuman Genome Project and Celera Genomics

Back toTImeline

http://biotechnology.amgen.com/timeline-medical-biotechnology

2001

Magazines having to do with nature and science publish the humangenome sequence. This makes the sequence viewable to scientistsall over the world. This sequence can be used to start researchingpossible new treatments for genetic diseases like heart disease,cancer, Alzheimer’s and Parkinson’s disease.

Back toTImeline

http://biotechnology.amgen.com/timeline-medical-biotechnology

2002

Major genomes of the mouse, chimpanzee, dog and hundreds ofother organisms are completed.

Back toTImeline

http://biotechnology.amgen.com/timeline-medical-biotechnology

2003

The human genome sequencing is finished by NIH and Celera.

Back toTImeline

http://biotechnology.amgen.com/timeline-medical-biotechnology

2004

“The FDA approves the first monoclonal antibody that is anantiangiogenic, inhibiting the growth of blood vessels—orangiogenesis—for cancer therapy.”

‹A DNA microarray test system that helps in choosing medications fordifferent conditions is cleared by the FDA. *This is importantbecause is a step forward to personalized medicine.